Profile
Redmile Group is a company based out of San Francisco.
Redmile Group is a hedge fund and private equity management company that does venture investments, private equity, and post IPO equity investments in the healthcare industry. The company was founded in 2007 and is based in San Francisco, California. It focuses on biotechnology, healthcare, therapeutics, life sciences, and the medical devices sector. The firm has invested in companies like AlloVir, IGM Biosciences, Saluda Medical, Repare Therapeutics, ArcherDX, Augmedix, and BioNTech. As of January 2020, the firm has had 38 exits.
Industry
Redmile Group Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Redmile Growth Investments I LP
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$157 M
|
February 2022
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Redmile Group — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Redmile Group
Is Redmile Group a venture capital or private equity firm?
Redmile Group is a venture capital firm. It backs companies at Seed, Series B and Series A, writing tickets of $0-1 m.
Where is Redmile Group located?
Redmile Group is located in San Francisco, California, United States.
When was Redmile Group founded?
Redmile Group was founded in 2007.
What sectors and industries does Redmile Group invest in?
Redmile Group invests in companies and startups in Fashion/Beauty, Healthcare Services, Other, Software, Transportation, HealthTech, Biotechnology, Medical Devices, Pharmaceuticals, Life Sciences.
What is Redmile Group geographical focus of investments?
Redmile Group invests in companies and startups in North America, Europe.
At what stages of companies and startups does Redmile Group typically invest in?
Redmile Group invests in companies and startups at Seed, Series B, Series A.
What is the usual amount of Redmile Group investment?
Redmile Group usually invests $0-1 m on average.
What is the amount of assets of under management (AUM) for Redmile Group?
Redmile Group has around $6 500m assets under management.
When was Redmile Group last fund created?
Redmile Group last fund was created/launched in 2022-02-09
What are the contacts of Redmile Group?
Redmile Group can be reached through its website redmilegroup.com and its LinkedIn page. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Redmile Group — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Redmile Group data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Redmile Group directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Redmile Group profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.